The purpose of this study is to determine whether pharmacogenomic study predict antidepressant responsiveness in advance before the appearance of the drug effects until 4\~6 weeks after drug administration.
The purpose of this study is 1. to determine whether genomic effects on antidepressant response differed by class of drug, 2. whether genomic differences between drug responders and nonresponders predict the response of antidepressant and 3. to construct the prediction model for antidepressant treatment in order to aid to select the their genetically matching drugs.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
1,000
Antidepressant administration of SSRI class for 6 weeks under therapeutic dose
Antidepressant administration of non-SSRI class for 6 weeks under therapeutic dose
Samsung Medical Center
Kangnam, Seoul, South Korea
RECRUITINGAntidepressant Response at 2,4,6 weeks A/E monitoring at 1,2,4,6 weeks
Time frame: 6 weeks
Biological value at 0 and 6 weeks
Time frame: 6weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.